Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-15
2006-08-15
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S461000, C514S468000, C514S529000, C424S725000, C424S774000
Reexamination Certificate
active
07091239
ABSTRACT:
A method of treating proliferative diseases in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of at least one compound selected from the group consisting of mikanolide and dihydromikanolide sufficient to treat said disease.
REFERENCES:
patent: 5773005 (1998-06-01), Takahashi et al.
patent: 07267940 (1995-10-01), None
Ahmed, M. Pharmazie. 1990. Further Dilactones from Mikania cordata. vol. 45, H.9, p. 697.
Brezak Pannetier Marie-Christine
Moumen Mohamed
Prevost Grégoire
Teng Poon Beng
Muserlian Charles A.
Societe de Conseils de Recherches et d'Applications Scientifique
Tate Christopher R.
LandOfFree
DNA polymerase inhibitors, mikanolide and dihydromikanolide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA polymerase inhibitors, mikanolide and dihydromikanolide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA polymerase inhibitors, mikanolide and dihydromikanolide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3671077